Table 5.
Results by case in Tests 1 and 2. Percent exactly correct and correct or acceptable replies in percent and number
| Test 1 | Test 2 | ||||
|---|---|---|---|---|---|
| Case | Diagnosis | % correct (95% CI) | % correct or acceptable (95% CI) | % correct (95% CI) | % correct or acceptable (95% CI) |
| 1 | Adenosis | 26.3 (20.7–32.6) | 79.5 (73.6–84.6) | 50.0 (43.3–56.7) | 89.3 (84.5–93.0) |
| 2 | Cancer | 36.6 (30.3–43.3) | 36.6 (30.3–43.3) | 52.2 (45.5–58.9) | 52.2 (45.5–58.9) |
| 3 | Partial atrophy | 27.2 (21.5–33.6) | 78.6 (72.6–83.8) | 24.6 (19.1–30.7) | 77.2 (71.2–82.6) |
| 4 | Cancer | 27.7 (21.9–34.0) | 27.7 (21.9–34.0) | 57.1 (50.4–63.7) | 57.1 (50.4–63.7) |
| 5 | Postatrophic hyperplasia | 27.7 (21.9–34.0) | 67.4 (60.8–73.5) | 45.1 (38.5–51.9) | 75.0 (68.8–80.5) |
| 6 | Clear cell cribriform hyperplasia | 55.4 (48.6–62.0) | 86.2 (80.9–90.4) | 61.6 (54.9–68.0) | 91.5 (87.1–94.8) |
| 7 | Seminal vesicle | 61.2 (54.4–67.6) | 69.6 (63.2–75.6) | 92.9 (88.7–95.9) | 95.5 (91.9–97.8) |
| 8 | Basal cell hyperplasia | 62.9 (56.3–69.3) | 72.3 (66.0–78.1) | 79.9 (74.1–85.0) | 84.8 (79.4–89.3) |
| 9 | Partial atrophy | 12.5 (8.5–17.6) | 70.5 (64.1–76.4) | 26.3 (20.7–32.6) | 78.6 (72.6–83.8) |
| 10 | Cancer | 50.9 (44.1–57.6) | 50.9 (44.1–57.6) | 79.0 (73.1–84.2) | 79.0 (73.1–84.2) |
| 11 | Partial atrophy | 11.2 (7.4–16.0) | 71.0 (64.6–76.8) | 22.8 (17.4–28.8) | 71.9 (65.5–77.7) |
| 12 | Postatrophic hyperplasia | 25.9 (20.3–32.1) | 76.8 (70.7–82.1) | 45.1 (38.5–51.9) | 83.5 (78.0–88.1) |
| 13 | Cancer | 21.0 (15.8–26.9) | 21.0 (15.8–26.9) | 38.4 (32.0–45.1) | 38.4 (32.0–45.1) |
| 14 | Partial atrophy | 7.6 (4.5–11.9) | 91.5 (87.1–94.8) | 11.6 (7.7–16.5) | 89.3 (84.5–93.0) |
| 15 | Cancer | 17.0 (12.3–22.5) | 17.0 (12.3–22.5) | 20.5 (15.4–26.4) | 20.5 (15.4–26.4) |
| 16 | Adenosis | 38.4 (32.0–45.1) | 54.0 (47.3–60.7) | 61.2 (54.4–67.6) | 70.5 (64.1–76.4) |